Global Veterinary Anti-Infectives 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR122414325

Publication Date:

December 30, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Veterinary Anti-Infectives market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Europe and Asia Pacific are growing regions in this market, but North America is the most lucrative among the other regions. This can be attributed to an increase in pet ownership and soaring demand for improved nutrition, especially animal protein. Widened focus on food safety also contributes to the higher demand.
The fast growth in the Asia Pacific (APAC) region can be attributed to trends such as promotion of small animal care, the livestock segment fueling the market for veterinary therapeutics, and key players focusing on distribution partnerships in India.
This report includes an overview of the development of the Veterinary Anti-Infectives industry chain, the market status of Companion Animals (Marbofloxacin, Florfenicol), Farm Animals (Marbofloxacin, Florfenicol), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Veterinary Anti-Infectives.
Regionally, the report analyzes the Veterinary Anti-Infectives markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Veterinary Anti-Infectives market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Veterinary Anti-Infectives market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Veterinary Anti-Infectives industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Marbofloxacin, Florfenicol).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Veterinary Anti-Infectives market.
Regional Analysis: The report involves examining the Veterinary Anti-Infectives market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Veterinary Anti-Infectives market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Veterinary Anti-Infectives:
Company Analysis: Report covers individual Veterinary Anti-Infectives players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Veterinary Anti-Infectives This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Companion Animals, Farm Animals).
Technology Analysis: Report covers specific technologies relevant to Veterinary Anti-Infectives. It assesses the current state, advancements, and potential future developments in Veterinary Anti-Infectives areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Veterinary Anti-Infectives market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Veterinary Anti-Infectives market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Marbofloxacin
Florfenicol
Freeze-dried Ceftiofur
Beta-lactams
Oxytetracycline
Aminosidine
麻豆原创 segment by Application
Companion Animals
Farm Animals
Others
麻豆原创 segment by players, this report covers
Zoetis Animal Healthcare
Merck
Merial (Sanofi)
Elanco
Bayer Healthcare
Ceva Animal Health
Virbac
Boehringer Ingelheim
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Veterinary Anti-Infectives product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Veterinary Anti-Infectives, with revenue, gross margin and global market share of Veterinary Anti-Infectives from 2019 to 2024.
Chapter 3, the Veterinary Anti-Infectives competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Veterinary Anti-Infectives market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Veterinary Anti-Infectives.
Chapter 13, to describe Veterinary Anti-Infectives research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Veterinary Anti-Infectives
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Veterinary Anti-Infectives by Type
1.3.1 Overview: Global Veterinary Anti-Infectives 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Veterinary Anti-Infectives Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Marbofloxacin
1.3.4 Florfenicol
1.3.5 Freeze-dried Ceftiofur
1.3.6 Beta-lactams
1.3.7 Oxytetracycline
1.3.8 Aminosidine
1.4 Global Veterinary Anti-Infectives 麻豆原创 by Application
1.4.1 Overview: Global Veterinary Anti-Infectives 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Companion Animals
1.4.3 Farm Animals
1.4.4 Others
1.5 Global Veterinary Anti-Infectives 麻豆原创 Size & Forecast
1.6 Global Veterinary Anti-Infectives 麻豆原创 Size and Forecast by Region
1.6.1 Global Veterinary Anti-Infectives 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Veterinary Anti-Infectives 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Veterinary Anti-Infectives 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Veterinary Anti-Infectives 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Veterinary Anti-Infectives 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Veterinary Anti-Infectives 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Veterinary Anti-Infectives 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Zoetis Animal Healthcare
2.1.1 Zoetis Animal Healthcare Details
2.1.2 Zoetis Animal Healthcare Major Business
2.1.3 Zoetis Animal Healthcare Veterinary Anti-Infectives Product and Solutions
2.1.4 Zoetis Animal Healthcare Veterinary Anti-Infectives Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Zoetis Animal Healthcare Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Veterinary Anti-Infectives Product and Solutions
2.2.4 Merck Veterinary Anti-Infectives Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Merck Recent Developments and Future Plans
2.3 Merial (Sanofi)
2.3.1 Merial (Sanofi) Details
2.3.2 Merial (Sanofi) Major Business
2.3.3 Merial (Sanofi) Veterinary Anti-Infectives Product and Solutions
2.3.4 Merial (Sanofi) Veterinary Anti-Infectives Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Merial (Sanofi) Recent Developments and Future Plans
2.4 Elanco
2.4.1 Elanco Details
2.4.2 Elanco Major Business
2.4.3 Elanco Veterinary Anti-Infectives Product and Solutions
2.4.4 Elanco Veterinary Anti-Infectives Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Elanco Recent Developments and Future Plans
2.5 Bayer Healthcare
2.5.1 Bayer Healthcare Details
2.5.2 Bayer Healthcare Major Business
2.5.3 Bayer Healthcare Veterinary Anti-Infectives Product and Solutions
2.5.4 Bayer Healthcare Veterinary Anti-Infectives Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Bayer Healthcare Recent Developments and Future Plans
2.6 Ceva Animal Health
2.6.1 Ceva Animal Health Details
2.6.2 Ceva Animal Health Major Business
2.6.3 Ceva Animal Health Veterinary Anti-Infectives Product and Solutions
2.6.4 Ceva Animal Health Veterinary Anti-Infectives Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Ceva Animal Health Recent Developments and Future Plans
2.7 Virbac
2.7.1 Virbac Details
2.7.2 Virbac Major Business
2.7.3 Virbac Veterinary Anti-Infectives Product and Solutions
2.7.4 Virbac Veterinary Anti-Infectives Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Virbac Recent Developments and Future Plans
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business
2.8.3 Boehringer Ingelheim Veterinary Anti-Infectives Product and Solutions
2.8.4 Boehringer Ingelheim Veterinary Anti-Infectives Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Veterinary Anti-Infectives Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Veterinary Anti-Infectives by Company Revenue
3.2.2 Top 3 Veterinary Anti-Infectives Players 麻豆原创 Share in 2023
3.2.3 Top 6 Veterinary Anti-Infectives Players 麻豆原创 Share in 2023
3.3 Veterinary Anti-Infectives 麻豆原创: Overall Company Footprint Analysis
3.3.1 Veterinary Anti-Infectives 麻豆原创: Region Footprint
3.3.2 Veterinary Anti-Infectives 麻豆原创: Company Product Type Footprint
3.3.3 Veterinary Anti-Infectives 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Veterinary Anti-Infectives Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Veterinary Anti-Infectives 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Veterinary Anti-Infectives Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Veterinary Anti-Infectives 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Veterinary Anti-Infectives Consumption Value by Type (2019-2030)
6.2 North America Veterinary Anti-Infectives Consumption Value by Application (2019-2030)
6.3 North America Veterinary Anti-Infectives 麻豆原创 Size by Country
6.3.1 North America Veterinary Anti-Infectives Consumption Value by Country (2019-2030)
6.3.2 United States Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Veterinary Anti-Infectives Consumption Value by Type (2019-2030)
7.2 Europe Veterinary Anti-Infectives Consumption Value by Application (2019-2030)
7.3 Europe Veterinary Anti-Infectives 麻豆原创 Size by Country
7.3.1 Europe Veterinary Anti-Infectives Consumption Value by Country (2019-2030)
7.3.2 Germany Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Anti-Infectives Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Veterinary Anti-Infectives Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Veterinary Anti-Infectives 麻豆原创 Size by Region
8.3.1 Asia-Pacific Veterinary Anti-Infectives Consumption Value by Region (2019-2030)
8.3.2 China Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Veterinary Anti-Infectives Consumption Value by Type (2019-2030)
9.2 South America Veterinary Anti-Infectives Consumption Value by Application (2019-2030)
9.3 South America Veterinary Anti-Infectives 麻豆原创 Size by Country
9.3.1 South America Veterinary Anti-Infectives Consumption Value by Country (2019-2030)
9.3.2 Brazil Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Anti-Infectives Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Veterinary Anti-Infectives Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Veterinary Anti-Infectives 麻豆原创 Size by Country
10.3.1 Middle East & Africa Veterinary Anti-Infectives Consumption Value by Country (2019-2030)
10.3.2 Turkey Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Veterinary Anti-Infectives 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Veterinary Anti-Infectives 麻豆原创 Drivers
11.2 Veterinary Anti-Infectives 麻豆原创 Restraints
11.3 Veterinary Anti-Infectives Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Veterinary Anti-Infectives Industry Chain
12.2 Veterinary Anti-Infectives Upstream Analysis
12.3 Veterinary Anti-Infectives Midstream Analysis
12.4 Veterinary Anti-Infectives Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Zoetis Animal Healthcare
Merck
Merial (Sanofi)
Elanco
Bayer Healthcare
Ceva Animal Health
Virbac
Boehringer Ingelheim

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.